PMD חוב כולל להון psychemedics.com

Psychemedics (PMD) maintains its status as a leading developer in molecular hair analysis by investing in precision mass spectrometry. This price chart on GURU.Markets confirms financial stability, where the metric stands at 0.32. The business relies on external IT partners and logistics to scale its network, while operational processes are strictly governed by FDA regulations regarding the safe disposal of biomaterials.

For a defensive portfolio, assessing the debt load via the total liabilities-to-equity ratio is critical, as it determines the balance between financial stability and the pace of expansion. For Psychemedics (PMD), with its stable income from laboratory screening, the total debt relative to equity confirms the business's ability to operate without aggressive borrowing amidst limited market growth.